Expert Discusses Immunotherapy Growth in Treatment Landscape of NSCLC – Targeted Oncology
Targeted Oncology |
Expert Discusses Immunotherapy Growth in Treatment Landscape of NSCLC
Targeted Oncology Pecot: We have several different types of combinations. Ones that I discussed were chemotherapy plus immunotherapy, and some of those trials looked good and did work. Some are showing early signs of promise, but it is a little too early. There is a … |
